ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets

RTTNews | 1073 dias atrás
ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) announced Wednesday that it has received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Clorazepate Dipotassium Tablets.

ANI's Clorazepate Dipotassium Tablets are the generic version of the Reference Listed Drug (RLD) Tranxene.

The current annual U.S. market for Clorazepate Dipotassium Tablets is approximately $25.8 million, according to IQVIA/IMS Health, a leading healthcare data and analytics provider.

Marcadores : ANIP BPAX
read more
U.S. Stocks Broadly Lower In Cautious Trade

U.S. Stocks Broadly Lower In Cautious Trade

U.S. stocks are turning in a weak performance on Friday amid renewed concerns over trade tensions, and a batch of mixed economic data. The major averages all are down in negative territory, with the tech-laden Nasdaq underperforming.
RTTNews | 1h 13min atrás
Wall Street Likely To Open On Negative Note

Wall Street Likely To Open On Negative Note

Lower U.S. futures and uncertainty surrounding Trump administration's tariff moves point to a flat start for stocks on Wall Street on Friday. Investors will also be digesting some crucial economic data, including reports on U.S. consumer confidence, Chicago PMI reading, and personal income & spending reports.
RTTNews | 4h 36min atrás
Bay Street Likely To Open On Mixed Note

Bay Street Likely To Open On Mixed Note

Canadian shares are likely to open on a mixed note Friday morning with investors reacting to a slew of economic data, and assessing the likely move of Trump administration with regard to tariffs.
RTTNews | 4h 59min atrás